Dementia — A Systems Approach to Falls and Discharge Planning
Citation(s)
Duah-Owusu White M, Kelly F, Vassallo M, Nyman SR Understanding the hospital discharge planning process for medical patients with dementia. Contemp Nurse. 2023 Oct 21:1-11. doi: 10.1080/10376178.2023.2266530. Online ahead of print.
Duah-Owusu White M, Kelly F A narrative review of staff views about dementia care in hospital through the lens of a systems framework. J Res Nurs. 2023 Mar;28(2):120-140. doi: 10.1177/17449871221142104. Epub 2022 Dec 29.
Duah-Owusu White M, Vassallo M, Kelly F, Nyman S Can a systems approach reduce adverse outcomes in patients with dementia in acute settings? (innovative practice). Dementia (London). 2020 May;19(4):1280-1286. doi: 10.1177/1471301217737690. Epub 2017 Nov 3. No abstract available.
Duah-Owusu White M, Vassallo M, Kelly F, Nyman S Two factors that can increase the length of hospital stay of patients with dementia. Rev Esp Geriatr Gerontol. 2022 Nov-Dec;57(6):298-302. doi: 10.1016/j.regg.2022.10.004. Epub 2022 Nov 18.
Duah-Owusu White, M , Kelly, F., Vassallo, M., & Nyman, S. Using a systems perspective to understand hospital falls among patients with dementia. Aging and Health Research. 2022; 2(4).
Improving the Short Term Management of Patients With Dementia Admitted to Hospital
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
